Search clinical trials for: Trivalent oral polio vaccine

Total 27364 results

University of Maryland, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection

Salmonella

United States
University of Maryland, Baltimore
PATH

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Shigella

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

Shigella

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Shigella

United States
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Pandemic Influenza Disease

Finland, Germany
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
Johns Hopkins Bloomberg School of Public Health

Completed

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Cholera | Vibrio Cholerae Infection

Zambia
Danish Headache Center

Completed

Multiomics After Headache Provocation of People Who Are Unable to Have Headache

Healthy | Headache

Denmark
National Institute of Allergy and Infectious Diseases...

Completed

VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

Alphavirus Infections | Eastern Equine Encephalitis | Venezuelan Equine Encephalitis | Western Equine Encephalitis

United States
ImmunityBio, Inc.

Withdrawn

QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy

Merkel Cell Carcinoma
GlaxoSmithKline

Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Infections, Rotavirus | Rotavirus Vaccines

Philippines
Masaryk University
University of Kiel; University of Giessen; F.D. Roosevelt Teaching Hospital with... and other collaborators

Unknown

Oral Side Effects of COVID-19 Vaccine

Covid19 | Vaccine Adverse Reaction | Oral Manifestations

Czechia, Germany, Slovakia
Bharat Biotech International Limited
Indian Council of Medical Research; National Institutes of Health (NIH); Stanford... and other collaborators

Completed

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Diarrhea

India
Beni-Suef University
University of Arizona; Maternity and Children Hospital, Makkah; Benisuef university...

Completed

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

Sickle Cell Disease | Vaso-occlusive Crisis | Sickle Cell Anemia in Children

Egypt, Saudi Arabia
GlaxoSmithKline

Completed

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Sweden, Norway
GlaxoSmithKline
Novartis Vaccines

Completed

Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Streptococcus Agalactiae | GBS Disease

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

Urinary Tract Infection

United States
Oslo University Hospital
University Hospital, Akershus

Completed

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

Cervical Cancer | Cervical Intraepithelial Neoplasia | Oropharyngeal Cancer

Norway
Novartis Pharmaceuticals

Completed

A Phase I Study of Oral BGJ398 in Asian Patients

Tumor With Alterations of the FGF-R

China, Japan
Tasly Tianjin Biopharmaceutical Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

China
GlaxoSmithKline

Completed

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

Infections, Rotavirus

South Africa
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Confirmatory Study of BK1310 in Healthy Infants

Pertussis | Tetanus | Diphtheria | Bacterial Meningitis | Poliomyelitis

Japan
Boryung Biopharma Co., Ltd.

Unknown

To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years (Aladdin)

Pertussis | Tetanus | Diphtheria | Poliomyelitis

Korea, Republic of
Sinovac Biotech Co., Ltd

Completed

Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization

Poliomyelitis

China
GlaxoSmithKline

Completed

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

Infections, Streptococcal

Czechia
National Institute of Allergy and Infectious Diseases...

Completed

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Gastroenteritis Escherichia Coli

United States
Procter and Gamble

Completed

Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity

Dentinal Hypersensitivity

United States
China National Biotec Group Company Limited
Peking University; Beijing Institute of Biological Products Co Ltd.; Beijing...

Completed

Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

Vaccination

China
University of Vermont

Completed

Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

Polio

United States
University of Vermont
International Centre for Diarrhoeal Disease Research, Bangladesh; Thrasher... and other collaborators

Completed

The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity

Rotavirus Infection | Vaccine Response Impaired | Vaccine Virus Shedding

Bangladesh
Seqirus

Completed

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Influenza, Human

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Finland, Dominican Republic
Centers for Disease Control and Prevention, China
Shandong Province Centers for Disease Control and Prevention

Completed

Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China

Poliomyelitis

China
Centers for Disease Control and Prevention, China
World Health Organization; Shandong Province Centers for Disease Control and...

Completed

A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China.

Poliomyelitis

China
Mahidol University
World Health Organization; The Government Pharmaceutical Organization

Completed

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Influenza

Thailand
Tribhuvan University Teaching Hospital, Institute...
Centers for Disease Control and Prevention; World Health Organization

Completed

Persistence of IPV Immunity

Poliomyelitis

Nepal
Mahidol University
World Health Organization; The Government Pharmaceutical Organization

Completed

Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Influenza
PATH
The Emmes Company, LLC

Completed

Safety and Immunogenicity Study of Trivalent P2-VP8 Subunit Rotavirus Vaccine in Adults, Toddlers and Infants

Healthy

South Africa
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Healthy, no Evidence of Disease

United States
National Cancer Institute (NCI)

Terminated

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Sarcoma | Esophageal Cancer | Thymic Carcinoma | Lung Cancer | Malignant Pleural Mesothelioma

United States
Jiangsu Province Centers for Disease Control and...
Beijing Minhai Biotechnology Co., Ltd

Completed

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

Polio

China
Jiangsu Province Centers for Disease Control and...

Completed

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)

Polio

China
GlaxoSmithKline

Completed

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Tetanus | Diphtheria | Acellular Pertussis

United States
Boston Children's Hospital

Completed

Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study

Endometriosis

United States
Takeda

Terminated

IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults

Poliomyelitis

Panama
GlaxoSmithKline

Completed

Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Vietnam
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

Spain
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland

Search clinical trials for: Trivalent oral polio vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations